The Rapid Micro Blog

Our blog will keep you informed of new and noteworthy technologies, reviews of recent publications and presentations, upcoming conferences and training events, and what's changing in the rapid and alternative microbiological methods world.

FDA's Hussong Discusses Objectionable Organisms and RMMs

Dr. David Hussong, FDA CDER, reviewed the impact that B. cepacia can have on pharmaceutical product and the reasons why this organism may be considered objectionable for certain dosage forms. He stated that current test methods, including finished product testing, may not be sufficient in detecting objectionable organisms, and that it is more critical to look for these types of organisms during in-process screening using rapid methods. BlogBooster-The most productive way for mobile blogging. BlogBooster is a multi-service blog editor for iPhone, Android, WebOs and your desktop

Post a Comment

Previous Post Next Post

Contact Form